Good afternoon, and welcome to the Quarter One 2025 Vanda Pharmaceuticals Incorporated Earnings Conference Call. I am Franz, and I will be the operator assisting you today. All lines have been placed ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Vanda Pharmaceuticals Inc (VNDA) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Rising Losses
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Vanda Pharmaceuticals specializes in developing and commercializing therapies for neurological and rare disorders. Its main products include Fanapt®, an antipsychotic for schizophrenia and bipolar I ...
Vanda Pharmaceuticals Inc. (VNDA) has several of its pipeline products approved for certain disorders. Such approved therapies that this company has are Fanapt, HETLIOZ, and PONVORY. The last time I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results